Preventing prescription opioid abuse

JAMA - Journal of the American Medical Association

Volumn 313, Issue 10, 2015, Pages 1059-

  Ballantyne, Jane C ^a   Kolodny, Andrew ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Phoenix House   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; HYDROCODONE; NARCOTIC ANALGESIC AGENT;

DRUG COST; DRUG MARKETING; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; LETTER; LOW BACK PAIN; OPIATE ADDICTION; PRESCRIPTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; UNITED STATES; DRUG OVERDOSE;

ANALGESICS, OPIOID; DRUG OVERDOSE; HEALTH POLICY; HUMANS; HYDROCODONE;

EID: 84924386342     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.0521     Document Type: Letter

References (5)

1. University ofWisconsin-Madison Pain and Policy Studies Group. International Narcotics Control Board opioid consumption data. http://www.painpolicy.wisc.edu/opioid-consumption-data. Accessed October 14, 2014.
2. Franklin GM; American Academy of Neurology. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology. 2014;83(14):1277-1284.
3. Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses-a US epidemic. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm. Accessed January 17, 2015.
4. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: time to back off? J AmBoard Fam Med. 2009;22(1):62-68.
5. Jones CM, Lurie P,Woodcock J. Addressing prescription opioid overdose: data support a comprehensive policy approach. JAMA. 2014;312(17):1733-1734.